Author

K. Rajamaki

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 2 Assay:bulk RNA-seq· 1 Assay:clinical cohort / trial· 1 Approach:comparative / phylogenetic analysis· 1 Research Focus:differential expression· 1 Approach:experimental assay· 1 Research Focus:host-pathogen & immune response· 1 Organism:human· 1

Frequent Co-Authors

A. Ranki· 1 shared A. Sacchetti· 1 shared B. van der Steen· 1 shared D. Seinstra· 1 shared E. Einarsdottir· 1 shared E. Haapaniemi· 1 shared E. Morgunova· 1 shared H. Heikkila· 1 shared

Activity by Year

2018-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

A. Ranki

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

The origin of intestinal cancer in the context of inflammation

M. P. Verhagen, R. Joosten, M. Schmitt, N. Valimaki, A. Sacchetti, K. Rajamaki, J. Choi, P. Procopio, S. Silva, B. van der Steen, T. P. P. van den Bosch, D. Seinstra, M. Doukas, L. H. Augenlicht, L. A. Aaltonen, R. Fodde

The paper shows that secretory cell lineages, not stem cells, can trigger tumor formation in the context of inflammation and Western-style diets, which are major colon cancer risk factors.

bioRxiv · Oct 2, 2023 · PreprintCancer Biology

Characterization of novel TMEM173 mutation with additive IFIH1 risk allele

S. Keskitalo, E. Haapaniemi, E. Einarsdottir, K. Rajamaki, H. Heikkila, M. Ilander, M. Poyhonen, E. Morgunova, K. Hokynar, S. Lagstrom, S. Kivirikko, S. Mustjoki, K. Eklund, J. Saarela, J. Kere, , M. Varjosalo

The paper reports a novel gain-of-function TMEM173 mutation and its additive effects with IFIH1 risk allele on clinical phenotype in a multigeneration family.

bioRxiv · Aug 17, 2018Immunology